Company
GenoME Diagnostics
Our lead product for improved ovarian cancer monitoring and earlier recurrence detection.
- Status
- Operatingas of 2026-09-19Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
GenoME’s mission is to develop novel blood tests for early disease detection and unmet need.
Funding snapshot
- Latest round
- Undisclosed2023-03
Funding rounds
- Round, 2023
- 2023-03
- Pre seed
- 2021-05
Products
- Other
- OvaME™
- Other
- PanME™
Loading relationship preview